Author

A. A. Avdeeva

Observed names: A Avdeeva, ANASTASIA AVDEEVA, Anastasia Avdeeva

Institution: Association of Rheumatologists of Russia

Observed institution: Association of Rheumatologists of Russia

OpenAlex ID: A5008683949

The First Russian Strategic Study of Pharmacotherapy for Rheumatoid Arthritis (remarca Trial): Results of 12-month Treatment in 130 Patients

2014 · D. E. Karateev, E. L. Luchikhina, et al. · Rheumatology Science and Practice · 17

The First Russian Strategic Study of Pharmacotherapy for Rheumatoid Arthritis (remarca Trial): Results of 12-month Treatment in 130 Patients

2016 · D. E. Karatee, E. L. Luchikhina, et al. · Rheumatology Science and Practice · 1

Clinical and Immunological Features of Kidney Transplant Recipients With Cytomegalovirus Infection Manifestation in the Early Postoperative Period

2014 · L. V. Limareva, A. V. Kolsanov, et al. · Russian Journal of Transplantology and Artificial Organs · 1

PDF

P.092 Endothelin-1 and severity of disease and interstitial lung disease in scleroderma patients

2026 · Olga Ovsyannikova, Olga Koneva, et al. · Poster presentations

P.102 Association of interstitial lung disease (ILD) with markers of microvascular damage and fibrogenesis in systemic sclerosis (SSc

2026 · Olga Koneva, Rushana Shayachmetova, et al. · Poster presentations

P.196 Clinical and laboratory associations of TNF-alfa in patients with systemic scleroderma

2026 · Olga Koneva, Rushana Shayachmetova, et al. · Poster presentations

P.156 Monocyte chemoattractant protein-1 (MCP-1): association with the progression of skin and cardiovascular manifestations of systemic sclerosis (SSc

2026 · Olga Koneva, Liudmila Garzanova, et al. · Poster presentations

PDF

P.101 Markers of alveolar epithelial injury in patients with systemic scleroderma and interstitial lung disease (SSc-ILD): clinical and laboratory associations

2026 · Olga Konev, Liudmila Garzanova, et al. · Poster presentations

PO:02:040 The association between antibodies, complement C3/C4 and clinical features in patients with systemic lupus erythematosus: criterial markers

2026 · Tatiana Panafidina, Tatiana Popkova, et al. · Lupus Science & Medicine

PDF

PO:02:039 The association between antibodies and clinical features in patients with systemic lupus erythematosus: non-criterial antibodies

2026 · Tatiana Panafidina, Tatiana Popkova, et al. · Lupus Science & Medicine

PDF

PO:03:077 Antithyroid antibodies and thyroid dysfunction in women with systemic lupus erythematosus

2026 · Liubov Kondrateva, Tatiana Panafidina, et al. · Lupus Science & Medicine

PDF

PO:02:051 Diabetes mellitus – associated antibodies in women with systemic lupus erythematosus

2026 · Liubov Kondrateva, Tatiana Panafidina, et al. · Lupus Science & Medicine

PDF

PO:02:041 The frequency of different spectrum of antibodies and complement C3/C4 in patients with systemic lupus erythematosus

2026 · Tatiana Panafidina, Tatiana Popkova, et al. · Lupus Science & Medicine

PDF

New Biomarkers of Cardiovascular Risk and Subclinical Left Ventricular Dysfunction in Patients With Rheumatoid Arthritis

2024 · YULIA N GORBUNOVA, TATIANA POPKOVA, et al. · CHEST Journal

PO.2.36 Characterization of peripheral blood b-cell subset in untreated patients with systemic lupus erythematosus

2022 · E Gerasimova, D Tabakov, et al. · Lupus Science & Medicine

PDF

The First Russian Strategic Study of Pharmacotherapy for Rheumatoid Arthritis (remarca Trial): Results of 12-month Treatment in 130 Patients

2015 · D. E. Karateev, E. L. Luchikhina, et al. · Rheumatology Science and Practice

Works count: 16

Citation count: 19

H-index: 1

I10-index: 1